SHC (Sotera Health Corp) Company Assets

SHC (Sotera Health Corp) - company brandmark

Sotera Health Company (SHC) operates within a tight oligopoly with high barriers to entry, making the competition for contracts a key factor. Meanwhile, the business is burdened by debt and environmental lawsuits, although external logistics have been optimized. Total assets on the GURU.Markets daily chart reflect resource dynamics, where 3263.07 expresses today's metric value.

SHC - Sotera Health Company Company Total Assets over the range 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Sterigenics (SHC)

- price and consensus price forecast:
Stock Quotes soterahealth.com|SHC - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Nordion|SHC - Enterprise Value
- balance sheet equity data:
Equity per Share Sotera Health|SHC - Book Capitalization|Market Capitalization to Book Value Ratio soterahealth.com|SHC - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio Sotera Health Company|SHC - Long-Term Debt to Capital|Short-Term Debt to Capital Nordion|SHC - Company Debts|Debt to Book Capitalization Ratio Nordion|SHC - Company Long-Term Liabilities|Short-Term Debt Sotera Health|Interim Coverage Ratio soterahealth.com
- earnings and market ratios statistics:
SHC - Net Profit
Basic company analysis:soterahealth.com, SHC
Brand item of Sterigenics

Total assets represent the aggregate resource base of Sotera Health Company (SHC), calculated inversely via ROA to assess the scale of capital and liabilities. This total assets chart allows investors to correlate physical business growth with efficiency, which is critical for Sotera Health Company (SHC) as it expands sterilization capacities under the leadership of Michael Petras Jr.

Key competitors

Cumulative Company Assets agilent.com|DGX (Quest Diagnostics Incorporated) - Company Total Assets|Company Assets Illumina Inc ILMN|Company Total Assets EXAS|Revvity Corp - Total Business Assets|Company Total Assets BIO (Bio-Rad Laboratories)|Company Total Assets anbio.com NNNN|QDEL - Aggregate Company Assets|OPK (OPKO Health Inc) - Total Business Assets|CDNA: Company Total Assets|Maravai (MRVI) - Company Total Assets|Aggregate Company Assets Fulgent Genetics, Inc.|Aggregate Company Assets LAB|Cumulative Company Assets CTKB (Cytek Biosciences)|OSUR - Company Assets|Aggregate Company Assets Exagen XGN|Company Total Asset Base MDxHealth, Inc. (MDXH)|Lucid Diagnostics Inc. - Company Total Assets|Company Total Asset Base Prenetics Global PRE|imdxinc.com (IMDX) - Aggregate Company Assets|TRIB - Company Total Asset Base|Aggregate Company Assets ProPhase|Ainos Corporation (AIMD) - Company Total Asset Base|Aggregate Company Assets Co-Diagnostics, Inc. (CODX)|HSCS - Company Assets|Biomerica - Cumulative Company Assets|Aggregate Business Assets CDIO (Cardio Diagnostics Holdings Inc.)|Virax Biolabs Group Ltd - Company Total Assets|Company Assets Bluejay Diagnostics Corp|Aspira Women's Health (AWH) - Aggregate Company Assets|acceleratediagnostics.com - Aggregate Asset Value|CNTG (CENTOGENE N.V.) - Company Total Assets|Company Total Assets Enzo|Cumulative Company Assets FRES (Fresh2 Group Limited)|GENE (gtglabs.com) - Aggregate Asset Value|Company Total Assets ME (23andMe Holding Co.)|Aggregate Asset Value PMD